Osborne Clarke advises on the sale of Breath Therapeutics to Zambon
Osborne Clarke in Amsterdam has advised Breath and existing shareholders Gimv, Sofinnova Partners, Gilde Healthcare and founders on the sale...
Published on
26/07/2019
Read time
1m